Fust Matthew K

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$105,000.00
Insider Sells Quantity
17
Insider Sells Sum
$6.9M

Insider Activity of Fust Matthew K

According to the SEC Form 4 filings, Fust Matthew K, being in a position of

  1. director at Crinetics Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 47500 shares for $2.1M,
    over all time since 2019-12-16, has bought 0 shares, and sold 90200 shares for $2.99M.

The largest purchase of all time was on 2014-01-30 and amounted to 5000 shares of Ultragenyx Pharmaceutical Inc. for $105,000.

The largest sale of all time was on 2024-03-20 and amounted to 47500 shares of Crinetics Pharmaceuticals, Inc. for $2.1M.

Biography of Fust Matthew K

No biography is available at this moment.

2024-03-20SaleCrinetics Pharmaceuticals, Inc.
CRNX
director
47,500
0.0593%
$44.28$2.1M+10.74%
2024-03-07SaleUltragenyx Pharmaceutical Inc.
RARE
director
12,195
0.0147%
$50.88$620,443-7.65%
2022-07-13SaleCrinetics Pharmaceuticals, Inc.
CRNX
5,700
0.0102%
$20.96$119,455-12.86%
2021-11-04SaleAtara Biotherapeutics, Inc.
ATRA
director
13,354
0.0134%
$19.50$260,403-63.25%
2021-11-01SaleCrinetics Pharmaceuticals, Inc.
CRNX
director
8,954
0.0221%
$25.50$228,327-26.08%
2021-09-08SaleCrinetics Pharmaceuticals, Inc.
CRNX
director
6,046
0.0165%
$25.50$154,173-15.74%
2021-07-26SaleCrinetics Pharmaceuticals, Inc.
CRNX
director
5,000
0.0139%
$19.59$97,950+11.83%
2021-07-19SaleCrinetics Pharmaceuticals, Inc.
CRNX
director
5,000
0.0131%
$19.50$97,500+4.75%
2021-07-12SaleCrinetics Pharmaceuticals, Inc.
CRNX
director
5,000
0.013%
$20.71$103,550-1.93%
2020-07-06SaleUltragenyx Pharmaceutical Inc.
RARE
director
6,181
0.0106%
$90.00$556,290+22.94%
2020-07-01SaleUltragenyx Pharmaceutical Inc.
RARE
director
5,000
0.0083%
$85.00$425,000+25.99%
2020-05-18SaleUltragenyx Pharmaceutical Inc.
RARE
director
1,875
0.0032%
$75.00$140,625+46.65%
2020-04-22SaleUltragenyx Pharmaceutical Inc.
RARE
director
1,875
0.0031%
$65.00$121,875+46.16%
2019-12-16SaleCrinetics Pharmaceuticals, Inc.
CRNX
director
7,000
0.0157%
$12.21$85,435-29.45%
2019-02-06SaleMacroGenics, Inc.
MGNX
director
13,848
0.0294%
$24.77$342,946-43.73%
2018-05-30SaleUltragenyx Pharmaceutical Inc.
RARE
director
12,638
0.0253%
$72.00$909,939-8.67%
2018-05-14SaleAtara Biotherapeutics, Inc.
ATRA
director
12,286
0.0272%
$43.57$535,301-13.66%
2014-01-30PurchaseUltragenyx Pharmaceutical Inc.
RARE
director
5,000
0.0115%
$21.00$105,000
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.